Cost effectiveness analysis of FDG-PET in the differential diagnosis and staging of lung cancer in Japan

Kakuigaku

Volumn 34, Issue 5, 1997, Pages 329-336

  Kubota, Kazuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

18F fluorodeoxyglucose (FDG); Cost effectiveness analysis; Lung cancer; Positron emission tomography (PET); Tumor imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL DIAGNOSIS; HUMAN; JAPAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; POSITRON EMISSION TOMOGRAPHY;

COST-BENEFIT ANALYSIS; DEOXYGLUCOSE; DIAGNOSIS, DIFFERENTIAL; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; LUNG NEOPLASMS; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030812351     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Duhaylongsod PG, Lowe VJ, Pats EF, Vaughn AL, Coleman RE, Wolfe WG: Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxy-glucose positron emission tomography. J Thorac Cardiovasc Surg 110: 130-140, 1995
2. Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J: Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung cancer. J Nucl Med 37: 1428-1436, 1996